N-hydroxy 4-sulfonyl butanamide compounds
US6476027B1 · kind B1 · utility
7Cited by
3References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 1999 |
| Grant date | Nov 5, 2002 |
| Priority date | — |
| Expiry date | Dec 6, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/15
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
An N-hydroxy sulfonyl butanamide compound that inter alia inhibits matrix metalloprotease activity is disclosed as are a treatment process that comprises administering a contemplated N-hydroxy sulfonyl butanamide compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.